Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 110,475 | 117,755 | 148,451 | -187,353 | -141,327 |
| Depreciation Amortization | 1,109 | 714 | 344 | 1,229 | 897 |
| Accounts receivable | -750 | -13,074 | -14,549 | -2,599 | -245 |
| Accounts payable and accrued liabilities | -2,304 | 651 | 2,019 | -249 | 44 |
| Other Working Capital | 48 | -5,491 | 2,929 | -11,437 | -1,351 |
| Other Operating Activity | 26,219 | 30,993 | 21,977 | 39,540 | 27,121 |
| Operating Cash Flow | $134,797 | $131,548 | $161,171 | $-160,869 | $-114,861 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,417 | -1,285 | -565 | -1,931 | -1,642 |
| Investing Cash Flow | $-1,417 | $-1,285 | $-565 | $-1,931 | $-1,642 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 161 | 21 | 4 | 392,275 | 316,731 |
| Other Financing Activity | 0 | 0 | 0 | -454 | -454 |
| Financing Cash Flow | $161 | $21 | $4 | $391,821 | $316,277 |
| Beginning Cash Position | 561,380 | 561,380 | 561,380 | 332,359 | 332,359 |
| End Cash Position | 694,921 | 691,664 | 721,990 | 561,380 | 532,133 |
| Net Cash Flow | $133,541 | $130,284 | $160,610 | $229,021 | $199,774 |
| Free Cash Flow | |||||
| Operating Cash Flow | 134,797 | 131,548 | 161,171 | -160,869 | -114,861 |
| Capital Expenditure | -1,417 | -1,285 | -565 | -1,931 | -1,642 |
| Free Cash Flow | 133,380 | 130,263 | 160,606 | -162,800 | -116,503 |